BIOFUSE Trademark

Trademark Overview

On Monday, May 8, 2017, a trademark application was filed for BIOFUSE with the United States Patent and Trademark Office. The USPTO has given the BIOFUSE trademark a serial number of 87440435. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 3, 2025. This trademark is owned by EXTREMITY MEDICAL, LLC. The BIOFUSE trademark is filed in the Pharmaceutical Products category with the following description:

Medical and surgical devices, namely, a human bone allograft consisting of processed bone containing viable cells for use in bone regeneration, replacement or reconstruction in orthopedic fusion procedures

General Information

Serial Number87440435
Word MarkBIOFUSE
Filing DateMonday, May 8, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 3, 2025
Registration Number5495322
Registration DateTuesday, June 19, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Goods and ServicesMedical and surgical devices, namely, a human bone allograft consisting of processed bone containing viable cells for use in bone regeneration, replacement or reconstruction in orthopedic fusion procedures
Pseudo MarkBIO FUSE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 3, 2025
Primary Code005
First Use Anywhere DateTuesday, July 11, 2017
First Use In Commerce DateTuesday, July 11, 2017

Trademark Owner History

Party NameEXTREMITY MEDICAL, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameEXTREMITY MEDICAL, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameEXTREMITY MEDICAL, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, May 11, 2017NEW APPLICATION ENTERED
Friday, August 4, 2017NON-FINAL ACTION WRITTEN
Friday, January 26, 2018USE AMENDMENT FILED
Monday, February 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 13, 2017NOTICE OF PSEUDO MARK E-MAILED
Friday, August 4, 2017ASSIGNED TO EXAMINER
Friday, August 4, 2017NON-FINAL ACTION E-MAILED
Friday, August 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2018TEAS AMENDMENT OF USE RECEIVED
Saturday, February 3, 2018ASSIGNED TO LIE
Tuesday, February 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2018AMENDMENT TO USE PROCESSING COMPLETE
Friday, February 23, 2018USE AMENDMENT ACCEPTED
Saturday, February 24, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Monday, June 19, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 3, 2025CANCELLED SEC. 8 (6-YR)
Monday, November 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 26, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

biofuse bone replacement cells regeneration reconstruction procedures fusion orthopedic viable processed